Home ›
Entities
› academia
› Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA)
Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA)
Research article (Regulatory Toxicology and Pharmacology, 2024) · cited 67× · AI/ML
Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA)
Summary
Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA) is a scholarly article[1].
Key Facts
Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA)'s instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA). Retrieved May 24, 2026, from https://4ort.xyz/entity/determining-recommended-acceptable-intake-limits-for-n-nitrosamine-impurities-in-pharmaceuticals-development-and-applica
MLA“Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA).” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/determining-recommended-acceptable-intake-limits-for-n-nitrosamine-impurities-in-pharmaceuticals-development-and-applica.
BibTeX@misc{4ortxyz_determining-recommended-acceptable-intake-limits-for-n-nitrosamine-impurities-in-pharmaceuticals-development-and-applica_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA)}}, year = {2026}, url = {https://4ort.xyz/entity/determining-recommended-acceptable-intake-limits-for-n-nitrosamine-impurities-in-pharmaceuticals-development-and-applica}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA) — https://4ort.xyz/entity/determining-recommended-acceptable-intake-limits-for-n-nitrosamine-impurities-in-pharmaceuticals-development-and-applica (retrieved 2026-05-24)
